CDC says JN.1 variant accounts for about 86% of COVID cases in US

By Reuters
| January 23, 2024

There is no evidence that JN.1 causes more severe disease than other variants. Currently available vaccines are expected to increase protection against the variant.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...